Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Change in Receivables data on file, last reported at $614.1 million in Q1 2026.

• On a quarterly basis, Change in Receivables fell 4.05% year-over-year to $614.1 million in Q1 2026; TTM through Mar 2026 was $2.6 billion, a 2.96% increase from a year earlier, with the FY2025 full-year figure at $2.7 billion, up 4.05% from the prior year.
• Change in Receivables for Q1 2026 stood at $614.1 million, down from $697.7 million in the prior quarter.
• Over the last five years, Change in Receivables for BIO reached as high as $717.4 million in Q4 2022 and fell as low as $614.1 million in Q1 2026.
• Historically, Change in Receivables has averaged $659.2 million across 5 years, with a median of $655.5 million in 2024.
• Across the five-year window, Change in Receivables decreased 10.72% in 2022 and advanced 10.38% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $717.4 million in 2022, then decreased by 5.68% to $676.7 million in 2023, then dropped by 6.59% to $632.1 million in 2024, then advanced by 10.38% to $697.7 million in 2025, then fell by 11.98% to $614.1 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $614.1 million in Q1 2026, $697.7 million in Q4 2025, and $653.8 million in Q3 2025.